NEW YORK (GenomeWeb News) - Geospiza today said it has completed a $3 million round of series A stock financing.
 
Geospiza, which sells genomic data-management software, said it intends to use the funds to add product and sales staff to meet increasing demand.
 
The company said it will also use the funds to expand a collaboration with Applied Biosystems that the companies began in 2005 and expanded in August.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.